PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
58.07%
Positive revenue growth while AR is negative. John Neff might see a notable competitive edge here.
163.75%
Gross profit growth above 1.5x AR's 4.45%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
206.96%
EBIT growth below 50% of AR's 674.73%. Michael Burry would suspect deeper competitive or cost structure issues.
206.96%
Operating income growth under 50% of AR's 674.73%. Michael Burry would be concerned about deeper cost or sales issues.
23.23%
Net income growth under 50% of AR's 467.22%. Michael Burry would suspect the firm is falling well behind a key competitor.
23.20%
EPS growth under 50% of AR's 471.15%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
23.41%
Diluted EPS growth under 50% of AR's 471.15%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.05%
Share reduction while AR is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.23%
Diluted share count expanding well above AR's 0.00%. Michael Burry would fear significant dilution to existing owners' stakes.
2.75%
Dividend growth of 2.75% while AR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
52.01%
OCF growth above 1.5x AR's 2.84%. David Dodd would confirm a clear edge in underlying cash generation.
95.51%
FCF growth above 1.5x AR's 6.48%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-66.84%
Negative 10Y revenue/share CAGR while AR stands at 360.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-52.62%
Negative 5Y CAGR while AR stands at 360.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
12.06%
3Y revenue/share CAGR under 50% of AR's 360.00%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-61.62%
Negative 10Y OCF/share CAGR while AR stands at 258.59%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-70.06%
Negative 5Y OCF/share CAGR while AR is at 258.59%. Joel Greenblatt would question the firm’s operational model or cost structure.
-65.27%
Negative 3Y OCF/share CAGR while AR stands at 258.59%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-573.05%
Negative 10Y net income/share CAGR while AR is at 492.60%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-278.61%
Negative 5Y net income/share CAGR while AR is 492.60%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
13.02%
Below 50% of AR's 492.60%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
-50.44%
Negative equity/share CAGR over 10 years while AR stands at 222.67%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-66.09%
Negative 5Y equity/share growth while AR is at 222.67%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
6.58%
Below 50% of AR's 222.67%. Michael Burry suspects a serious short-term disadvantage in building book value.
-39.24%
Cut dividends over 10 years while AR stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-77.36%
Negative 5Y dividend/share CAGR while AR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-77.37%
Negative near-term dividend growth while AR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-6.13%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-69.64%
Inventory is declining while AR stands at 25.60%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-9.18%
Negative asset growth while AR invests at 8.34%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-14.01%
We have a declining book value while AR shows 12.69%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-1.51%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-1.04%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.